These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 31730152)

  • 1. Intravenous Ondansetron in Pregnancy and Risk of Congenital Malformations.
    Huybrechts KF; Hernandez-Diaz S; Straub L; Gray KJ; Zhu Y; Mogun H; Bateman BT
    JAMA; 2020 Jan; 323(4):372-374. PubMed ID: 31730152
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association of Maternal First-Trimester Ondansetron Use With Cardiac Malformations and Oral Clefts in Offspring.
    Huybrechts KF; Hernández-Díaz S; Straub L; Gray KJ; Zhu Y; Patorno E; Desai RJ; Mogun H; Bateman BT
    JAMA; 2018 Dec; 320(23):2429-2437. PubMed ID: 30561479
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ondansetron in pregnancy revisited: Assessment and pregnancy labelling by the European Medicines Agency (EMA) & Pharmacovigilance Risk Assessment Committee (PRAC).
    Damkier P; Kaplan YC; Shechtman S; Diav-Citrin O; Cassina M; Weber-Schoendorfer C
    Basic Clin Pharmacol Toxicol; 2021 Apr; 128(4):579-582. PubMed ID: 33275828
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Medications used to treat nausea and vomiting of pregnancy and the risk of selected birth defects.
    Anderka M; Mitchell AA; Louik C; Werler MM; Hernández-Diaz S; Rasmussen SA;
    Birth Defects Res A Clin Mol Teratol; 2012 Jan; 94(1):22-30. PubMed ID: 22102545
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ondansetron for Treatment of Nausea and Vomiting of Pregnancy and the Risk of Specific Birth Defects.
    Parker SE; Van Bennekom C; Anderka M; Mitchell AA;
    Obstet Gynecol; 2018 Aug; 132(2):385-394. PubMed ID: 29995744
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Risk of malformation after ondansetron in pregnancy: An updated systematic review and meta-analysis.
    Picot C; Berard A; Grenet G; Ripoche E; Cucherat M; Cottin J
    Birth Defects Res; 2020 Aug; 112(13):996-1013. PubMed ID: 32420702
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Nausea and vomiting in pregnancy: A place for ondansetron?].
    Coulm B
    Gynecol Obstet Fertil Senol; 2021 Dec; 49(12):947-950. PubMed ID: 34700033
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Epilepsy anticonvulsants and malformations.
    Annegers JF; Elveback LR; Hauser WA; Kurland LT
    Birth Defects Orig Artic Ser; 1975; 11(5):157-60. PubMed ID: 1218208
    [No Abstract]   [Full Text] [Related]  

  • 9. Teratogenicity of antiepileptic drugs.
    Starreveld-Zimmerman AA; van der Kolk WJ; Elshove J; Meinardi H
    Clin Neurol Neurosurg; 1975 Dec; 77(2):81-95. PubMed ID: 1132213
    [No Abstract]   [Full Text] [Related]  

  • 10. Birth defects related to bendectin use in pregnancy. I. Oral clefts and cardiac defects.
    Mitchell AA; Rosenberg L; Shapiro S; Slone D
    JAMA; 1981 Jun; 245(22):2311-4. PubMed ID: 7230459
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Congenital abnormalities and anticonvulsant drugs.
    Meadow SR
    Proc R Soc Med; 1970 Jan; 63(1):48-9. PubMed ID: 5417773
    [No Abstract]   [Full Text] [Related]  

  • 12. New evidence for concern over the risk of birth defects from medications for nausea and vomitting of pregnancy.
    Bérard A; Sheehy O; Gorgui J; Zhao JP; Soares de Moura C; Bernatsky S
    J Clin Epidemiol; 2019 Dec; 116():39-48. PubMed ID: 31352006
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Congenital deformities associated with Bendectin.
    Can Med Assoc J; 1977 Oct; 117(7):721-2. PubMed ID: 907941
    [No Abstract]   [Full Text] [Related]  

  • 14. Cardiac defects in children of mothers receiving anticonvulsant therapy during pregnancy.
    Anderson RC
    J Pediatr; 1976 Aug; 89(2):318-9. PubMed ID: 940034
    [No Abstract]   [Full Text] [Related]  

  • 15. Teratogenicity of anticonvulsant drugs.
    Annegers JF; Kurland LT; Hauser WA
    Res Publ Assoc Res Nerv Ment Dis; 1983; 61():239-48. PubMed ID: 6844727
    [No Abstract]   [Full Text] [Related]  

  • 16. First trimester ondansetron exposure and risk of structural birth defects.
    Zambelli-Weiner A; Via C; Yuen M; Weiner DJ; Kirby RS
    Reprod Toxicol; 2019 Jan; 83():14-20. PubMed ID: 30385129
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Case-control study of teratogenic potential of thiethylperazine, an anti-emetic drug.
    Czeizel AE; Vargha P
    BJOG; 2003 May; 110(5):497-9. PubMed ID: 12742335
    [TBL] [Abstract][Full Text] [Related]  

  • 18. American Academy of Pediatrics Committee on Drugs: anticonvulsants and pregnancy.
    Pediatrics; 1979 Feb; 63(2):331-3. PubMed ID: 440824
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Major Congenital Malformation Risk After First Trimester Gestational Exposure to Oral or Intravenous Ondansetron.
    Andrade C
    J Clin Psychiatry; 2020 Jun; 81(3):. PubMed ID: 32526103
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Congenital abnormalities, cleft lip and cleft palate in particular, in children of epileptic mothers].
    Elshove J; van Eck JH
    Ned Tijdschr Geneeskd; 1971 Aug; 115(33):1371-5. PubMed ID: 5565182
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.